Skip to main content
Podcasts

The STEMI of the Limb: Inspiring the Next Generation of Vascular Cardiologists

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates. 

Interview by Isabel Vega 

Join interventional cardiologist, Andrey Espinoza, MD, FACC, FSCAI, Advanced Heart and Vascular Institute of Hunterdon, Flemington, New Jersey, on Vascular Voices as he discusses his commentary, “The STEMI of the Limb: Have We Failed to Inspire the Next Generation of Vascular Cardiologists?” Discover how earlier exposure, mentorship, and multidisciplinary collaboration can strengthen cardiologists’ role in peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) care. This episode is also available on Spotify and Apple Podcasts.

Clinical Summary

  • Limb ischemia: Contemporary Medicare analyses cited by Dr Espinoza show 77% survival at 1 year after diagnosis.
  • Peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI): Recognize cardiovascular and limb risk; provide appropriate medical therapy and timely revascularization in selected patients. CLTI and STEMI both threaten viable tissue but are not pathophysiologically equivalent.
  • Limb preservation: Multidisciplinary care and earlier cardiovascular fellow exposure to vascular laboratories, limb ischemia clinics, wound care, and limb salvage conferences can support shared responsibility for PAD recognition and care.

Reviewed by Isabel Vega, Associate Digital Editor, Cardiovascular

Transcripts

What inspired you to write this commentary?
Dr Espinoza:
The inspiration was a pattern I kept seeing in both the training environment and private practice. A first-year fellow experiences an ST-segment elevation myocardial infarction (STEMI) activation and is immediately captured by the urgency, the systems, and the mission. Ask that same fellow about limb ischemia, and the response tends to be very different. It sits at the margins, perceived as the domain of vascular surgery, wound care, podiatry, or infectious disease.

I kept meeting patients whose limbs were lost on a slow, unhurried pathway that nobody would tolerate for a STEMI. The editorial asks whether the problem is not how much vascular medicine we teach, but how we teach young cardiologists to think about it.

Why is this conversation important now?
Dr Espinoza:
The outcomes for patients with limb ischemia are poor. This disease is not rare, and it certainly is not peripheral to our patients. Contemporary Medicare analyses show a 1-year survival rate of only 77% after a diagnosis of limb ischemia. These are not the outcomes of a benign disease in an expendable vascular territory.

Multisociety PAD guidelines give us clear direction on revascularization and limb preservation. Randomized data also support multidisciplinary vascular team care, including better attainment of lipid goals. The knowledge and tools already exist. What is missing in our cardiovascular environment is engagement, and building the workforce to deliver that care starts with cardiovascular fellows.

What do you hope the phrase “CLTI is the STEMI of the limb” communicates to trainees, and what should every cardiologist understand about PAD and CLTI?
Dr Espinoza:
The analogy is intentionally provocative, but it is an analogy. STEMI is usually an acute thrombotic event, whereas CLTI generally represents the culmination of chronic, progressive arterial insufficiency. The conditions are not pathophysiologically equivalent.

What they share is fundamental: ischemia threatens viable tissue. In STEMI, that tissue is the myocardium. In CLTI, tissue compromise threatens a functional limb. Both demand recognition of ischemia, appropriate medical therapy, and, in selected patients, timely revascularization. If time is muscle, time is also tissue.

The comparison is a teaching tool. Myocardium at risk becomes a limb at risk. Alongside major adverse cardiac events, we must consider major adverse limb events. Just as shock teams bring a multidisciplinary approach to cardiovascular care, limb salvage teams bring that approach to patients with threatened limbs.

Every cardiologist needs to understand that PAD is cardiovascular disease. It is predominantly atherosclerotic and carries substantial cardiovascular morbidity and mortality. Cardiologists already manage much of the biology that drives these outcomes, including dyslipidemia, diabetes mellitus, antithrombotic therapy, and polyvascular risk.

Why does vascular medicine receive less attention from fellows than structural heart disease, electrophysiology, and coronary intervention?
Dr Espinoza:
It is about identity, which forms around what fellows experience intensely and early in training. Fellows receive extensive exposure to structural heart disease, electrophysiology, complex coronary intervention, shock, and imaging. Those fields offer visible clinical pathways, technology, and clear career opportunities.

CLTI announces itself more quietly, perhaps in a wound clinic through which the fellow never rotates. Cardiovascular fellows rarely participate in wound management for patients with PAD.

The training framework exists. Vascular medicine is part of cardiovascular competency, and the 2023 advanced training statement for interventional cardiology explicitly includes peripheral vascular intervention. Professional identity has not followed that framework.

When fellows see aortic stenosis, they may wonder whether structural heart disease could be their career. When they see limb ischemia, the response too often is, “Let’s call vascular surgery.” That consultation is usually appropriate. The problem arises when it replaces the fellow’s curiosity and engagement because of a lack of comfort or exposure.

How can earlier exposure, mentorship, and hands-on limb-preservation care inspire more fellows to pursue vascular medicine?
Dr Espinoza:
We need to recruit fellows before they choose their professional identity. If we wait until interventional fellowship, after they have completed cardiovascular disease training, we may already be too late. By then, many have decided what kind of cardiologist they want to become.

The objective is twofold. Every cardiologist should graduate recognizing PAD, and particularly CLTI, as cardiovascular conditions for which they share responsibility. A subset of fellows also needs enough real-world exposure to say, “This is what I want to do.” That is more meaningful than another lecture on PAD.

Fellows should spend time in the vascular laboratory, understand duplex imaging, and consider certification in vascular interpretation. They should attend limb ischemia clinics and limb salvage conferences, work with vascular surgeons, and understand both the indications for bypass surgery and what it involves. They also need exposure to wound healing and the opportunity to follow patients who return weeks later with a closed wound and a preserved foot.

Mentorship matters because young physicians are attracted not simply to disease conditions, but to missions. We have a responsibility to show them that limb preservation is an extraordinary mission, and one we all share.

How can specialties work together to improve PAD care, and what is the main message you hope readers take away?
Dr Espinoza:
I have been doing this for almost 30 years, and I continue to see the turf battles I hoped would have disappeared. When physicians work individually in silos, the approach fails. No specialty owns PAD. We are all part of the process, and CLTI is one of the clearest examples of a disease that benefits from multidisciplinary care.

That team needs vascular surgeons, interventional cardiologists, interventional radiologists, vascular medicine specialists, podiatrists, nurses, and specialists in infectious disease, endocrinology, wound care, and rehabilitation. These are vital components of a successful program focused on the patient’s best interests.

The question should never be who owns PAD. From my perspective, it should be why every cardiologist does not feel responsible for recognizing the disease.
Language matters. Describing PAD as “peripheral” may be anatomically accurate, but culturally it implies something secondary. PAD is anything but peripheral to cardiovascular outcomes.

Cardiology has spent decades expanding what it can accomplish inside the heart, and we have done an incredible job. One of our next challenges may require rediscovering the rest of the circulation. This is a polyvascular disease state, and we cannot have tunnel vision.

CLTI is the STEMI of the limb because tissue is threatened. Time and expertise matter, and the outcome can preserve a limb and change a life.

The transcript has been edited for clarity and length.